LENTIVEX Trademark

Trademark Overview


On Friday, November 18, 2022, a trademark application was filed for LENTIVEX with the United States Patent and Trademark Office. The USPTO has given the LENTIVEX trademark a serial number of 79359897. The federal status of this trademark filing is REGISTERED as of Tuesday, July 9, 2024. This trademark is owned by Oxford Genetics Ltd. The LENTIVEX trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human and animal stem cells for medical and veterinary purposes; preparations of microorganisms for medical and veterinary purposes; viral vectors being tissue cultures for medical and veterinary purposes; lentiviruses, lentivirus particles and lentivirus plasmids for medical and veterinary use being biological preparations for the treatment of cardiovascular, degenerative, dermatological, endocrine, gastrointestinal, genetic, gynaecological, neurological, infectious, immunological, metabolic, oncological, ophthalmic, respiratory and urological disorders and diseases

Chemical and biological preparations for use in science and industry; nucleic acids for laboratory use; nucleic recombinant acids for laboratory use, synthetic deoxyribonucleic acids for laboratory use; chemical and biological reagents for non-medical and non-veterinary purposes; chemical and biological reagents for scientific and research purposes; human and animal stem cells for non-medical and non-veterinary purposes; microorganisms for non-medical purposes being cultures of microorganisms other than for medical and veterinary use; human and animal stem cells for scientific and research purposes; cultures of microorganisms for scientific and research purposes; viral vectors being chemicals and biological preparations for use in science and industry; lentiviruses, lentivirus particles and lentivirus plasmids being chemicals and biological preparations for scientific and research purposes

Product design and development services relating to the creation and alteration of chemical and biological reagents; new product design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; new product design services relating to the creation and alteration of recombinant viruses; new product design services relating to the creation and alteration of lentiviruses, lentivirus particles and lentivirus plasmids; scientific research, product development and bioengineering services relating to lentiviruses; drug discovery services; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof being drug discovery services; design services relating to the creation and alteration of viral vectors being drug discovery services; information and advice relating to all the aforesaid services
lentivex

General Information


Serial Number79359897
Word MarkLENTIVEX
Filing DateFriday, November 18, 2022
Status700 - REGISTERED
Status DateTuesday, July 9, 2024
Registration Number7435355
Registration DateTuesday, July 9, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements


Goods and ServicesChemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human and animal stem cells for medical and veterinary purposes; preparations of microorganisms for medical and veterinary purposes; viral vectors being tissue cultures for medical and veterinary purposes; lentiviruses, lentivirus particles and lentivirus plasmids for medical and veterinary use being biological preparations for the treatment of cardiovascular, degenerative, dermatological, endocrine, gastrointestinal, genetic, gynaecological, neurological, infectious, immunological, metabolic, oncological, ophthalmic, respiratory and urological disorders and diseases
Goods and ServicesChemical and biological preparations for use in science and industry; nucleic acids for laboratory use; nucleic recombinant acids for laboratory use, synthetic deoxyribonucleic acids for laboratory use; chemical and biological reagents for non-medical and non-veterinary purposes; chemical and biological reagents for scientific and research purposes; human and animal stem cells for non-medical and non-veterinary purposes; microorganisms for non-medical purposes being cultures of microorganisms other than for medical and veterinary use; human and animal stem cells for scientific and research purposes; cultures of microorganisms for scientific and research purposes; viral vectors being chemicals and biological preparations for use in science and industry; lentiviruses, lentivirus particles and lentivirus plasmids being chemicals and biological preparations for scientific and research purposes
Goods and ServicesProduct design and development services relating to the creation and alteration of chemical and biological reagents; new product design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; new product design services relating to the creation and alteration of recombinant viruses; new product design services relating to the creation and alteration of lentiviruses, lentivirus particles and lentivirus plasmids; scientific research, product development and bioengineering services relating to lentiviruses; drug discovery services; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof being drug discovery services; design services relating to the creation and alteration of viral vectors being drug discovery services; information and advice relating to all the aforesaid services

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, January 9, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 9, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 9, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOxford Genetics Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameOxford Genetics Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameOxford Genetics Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, August 31, 2023NON-FINAL ACTION WRITTEN
Friday, January 6, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, January 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 13, 2023APPLICATION FILING RECEIPT MAILED
Thursday, August 31, 2023ASSIGNED TO EXAMINER
Friday, September 1, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 20, 2023REFUSAL PROCESSED BY MPU
Wednesday, September 20, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 11, 2023REFUSAL PROCESSED BY IB
Tuesday, March 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 10, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 10, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2024NOTIFICATION PROCESSED BY IB
Friday, June 7, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, June 7, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sunday, June 30, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, July 9, 2024REGISTERED-PRINCIPAL REGISTER
Sunday, January 5, 2025FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, July 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, October 9, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, November 8, 2024NEW REPRESENTATIVE AT IB RECEIVED
Monday, December 16, 2024FINAL DISPOSITION NOTICE SENT TO IB
Monday, December 16, 2024FINAL DISPOSITION PROCESSED
Friday, February 14, 2025NEW REPRESENTATIVE AT IB RECEIVED